What are the options now? Recalls leaves millions of heartburn sufferers seeking safe and effective alternative treatments.
Walgreens announced that they will stop selling the popular heartburn medicine Zantac and generic versions of the drug after the Food and Drug Administration announced that traces of a known carcinogen were found in some of the products.
The move comes just days after CVS Health Corp announced that it was also pulling Zantac from their shelves.
The FDA said earlier this month that small amounts N-nitrosodimethylamine (NDMA) were found in samples of ranitidine, most commonly marketed as Zantac in the US and Canada. NDMA has been linked to an increased risk of colorectal and uterine cancers. The recall was issued by Apotex Corp who manufacturers the drug for Walgreens, Walmart, and Rite-Aid.
The recall heightens the need for those suffering with Gastoesophageal Reflux Disease (GERD) to find alternative treatment methods for their heartburn and other reflux symptoms. The company on the forefront of developing an alternative to Zantac and other anti-reflux medications is Amenity Health, Inc. The company developed and markets MedCline, a Class I medical device that treats nighttime GERD and acid reflux.
MedCline facilitates positioning of patients on an incline as well as on their side to treat nighttime reflux, which has been shown to be the most dangerous form of reflux. Numerous clinical trials performed by research institutions throughout the US have shown that MedCline is far more effective than bed wedges and that quality of life is also significantly improved using the product. Compared to previous studies measuring the effectiveness of more power medications for reflux, MedCline has demonstrated superior symptom relief and health-related quality of life.